Clinical Reviews in Allergy

, Volume 1, Issue 1, pp 123–146 | Cite as

Adrenal corticosteroids in the treatment of asthma

  • Sheldon C. Siegel


Asthma Corticosteroid Allergy Clin Immunol Beclomethasone Dipropionate Chronic Asthma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hench PS, Kendall EC, Slocumb CH, Polley HF: The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone, compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clinic 24:181–197, 1949Google Scholar
  2. 2.
    Dluhy RG, Lauler DP, Thom GW: Pharmacology and chemistry of adrenal glucocorticoids. Med Clin North Am 57:1155–1165, 1973PubMedGoogle Scholar
  3. 3.
    Baxter JD, Funder JW: Hormone receptors. N Engl J Med 301:1149–1161, 1979PubMedGoogle Scholar
  4. 4.
    Morris HG: Factors that influence clinical responses to administered corticosteroids. J Allergy Clin Immunol 66:343–346, 1980PubMedCrossRefGoogle Scholar
  5. 5.
    Zurier RB, Weissman G: Anti-immunologic and anti-inflammatory effects of steroid therapy. Med Clin N Am 57:1295–1307, 1973PubMedGoogle Scholar
  6. 6.
    Fauci AS: Immunosuppressive and anti-inflammatory effects of glucocorticoids, in Baxter JD, Rousseau GG (eds): Glucocorticoid Hormone Action. New York, Springer-Verlag, 1979, pp 449–465Google Scholar
  7. 7.
    Slott RI, Zweiman B: Histologic studies of human skin test responses to ragweed and compound 48/80. II. Effects of corticosteroid therapy. J Allergy Clin Immunol 55:232–240, 1975PubMedCrossRefGoogle Scholar
  8. 8.
    Ellul-Micallef R, Fenech FF: Effect of intravenous prednisolone in asthmatics with diminished adrenergic responsiveness. Lancet 2:1269–1271, 1975PubMedCrossRefGoogle Scholar
  9. 9.
    Stephan WC, Chick TW, Avner BP, Jenne JW: Tachyphylaxis to inhaled isoproterenol and the effect of methylprednisolone in dogs. J Allergy Clin Immunol 65:105–109, 1980PubMedCrossRefGoogle Scholar
  10. 10.
    Davies AO, Lefkowitz RJ: Agonist-promoted high affinity state of the β-adrenergic receptor in human neutrophils: Modulation by corticosteroids. J Clin Endocrinol Metab 53:703–708, 1981PubMedGoogle Scholar
  11. 11.
    Kirkpatrick CH: Steroid therapy of allergic diseases. Med Clin N Am 57:1309–1320, 1973PubMedGoogle Scholar
  12. 12.
    Claman HN: How corticosteroids work. J Allergy Clin Immunol 55:145–151, 1975PubMedCrossRefGoogle Scholar
  13. 13.
    Jansani MK: Possible modes of action of ACTH and glucocorticoids in allergic diseases. Clin Allergy 2:1–41, 1972CrossRefGoogle Scholar
  14. 14.
    DeVries K, Orie NGM: Corticosteroids and allergy. Scand J Respir Dis Suppl 68:24–30, 1969Google Scholar
  15. 15.
    Schayer RW: Induced synthesis of histamine, microcirculatory regulation and the mechanism of action of the adrenal glucocorticoid hormones, in Kallos P, et al (eds): Progress in Allergy. New York, S Karger, 1963, pp 187–212Google Scholar
  16. 16.
    Grzglewski RJ: Effects of anti-inflammatory steroids on arachidonate cascade. Adv Inflammation Res 1:505–513, 1979Google Scholar
  17. 17.
    Greaves MW, McDonald-Gibson W: Inhibition of prostaglandin biosynthesis by corticosteroids. Br Med J 2:83–84, 1972PubMedGoogle Scholar
  18. 18.
    Hammond CV, Hammond MD, Taylor WA: Selective inhibition by betamethasone of allergen-induced release of SRS-A from human lung. Int Arch Allergy Appl Immunol 67:284–286, 1982PubMedGoogle Scholar
  19. 19.
    Oertel H, Kaliner M: The biologic activity of mast cell granules in rat skin: Effects of adrenocorticoids on late-phase inflammatory responses induced by mast cell granules. J Allergy Clin Immunol 68:238–245, 1981PubMedCrossRefGoogle Scholar
  20. 20.
    Zweifach BW, Shorr E, Black MM: The influence of the adrenal cortex on behavior of the terminal vascular bed. Ann NY Acad Sci 56:626–633, 1953PubMedCrossRefGoogle Scholar
  21. 21.
    Claman HN: Corticosteroids and lymphoid cells. N Engl J Med 287:388–397, 1972PubMedGoogle Scholar
  22. 22.
    Stevenson HC, Fauci AS: Effects of corticosteroids on the function and distribution of human lymphocytes, in Franklin EC (ed): Clinical Immunology Update: Reviews for Physicians. New York, Elsevier Science Publishing Co., Inc., 1981, pp 337–355Google Scholar
  23. 23.
    Weissmann G, Thomas L: Studies on lysosomes. I. The effects of endotoxin, endotoxin tolerance, and cortisone on the release of acid hydrolysis from a granule fraction of rabbit liver. J Exp Med 116:433–450, 1962PubMedCrossRefGoogle Scholar
  24. 24.
    Ellul-Micallef R, Borthwick RC, McHardy JR: The effect of oral prednisolone on gas exchange in chronic bronchial asthma. Br J Clin Pharmacol 2:479–182, 1980Google Scholar
  25. 25.
    Logsdon PJ, Middleton E, Coffee RG: Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and nonasthmatic subjects. J Allergy Clin Immunol 50:45–56, 1972PubMedCrossRefGoogle Scholar
  26. 26.
    Fraser CM, Venter JC: The synthesis of β-adrenergic receptors in cultured human lung cells: Induction by glucocorticoids. Biochem Biophys Res Commun 94:390–397, 1980PubMedCrossRefGoogle Scholar
  27. 27.
    Thompson EB, Lippman ME: Mechanisms of action of glucocorticoids. Metabolism 23:159–202, 1974PubMedCrossRefGoogle Scholar
  28. 28.
    Middleton E: Mechanism of action of corticosteroids, in Stein M (ed): New Directions in Asthma. Park Ridge, Ill., American College of Chest Physicians, 1975, pp 433–446Google Scholar
  29. 29.
    Geddes BA, Lefcoe NM: Respiratory smooth muscle relaxing effect of commercial steroid preparations. Am Rev Respir Dis 107:395–399, 1973PubMedGoogle Scholar
  30. 30.
    Frigas E, Loegering DA, Gleich GJ: Cytotoxic effects of the guinea pig eosinophil major basis protein on tracheal epithelium. Lab Invest 42:35–43, 1980PubMedGoogle Scholar
  31. 31.
    Schatz M, Wasserman S, Patterson R: Eosinophils and immunologic lung disease. Med Clin North Am 65:1055–1071, 1981PubMedGoogle Scholar
  32. 32.
    Gleich GJ, Loegering DA, Frigas E, Wasson DL, Solley GO, Mann KG: The major basic protein of the eosinophil granule: Physiochemical properties, localization and function, in Mahmous AAF, Austen KF (eds): The Eosinophil in Health and Disease. New York, Grune & Stratton, 1980, pp 79–97Google Scholar
  33. 33.
    Hirsh SR: The role of mucus in asthma, in Stein M, (ed): New Directions in Asthma. Park Ridge, Ill., American College of Chest Physicians, 1975, pp 351–373Google Scholar
  34. 34.
    Collins JV, Clark TJH, Brow D, Townsend J: The use of corticosteroids in treatment of acute asthma. Q J Med 44:259–273, 1975PubMedGoogle Scholar
  35. 35.
    Pierson WE, Bierman CW, Kelley VC: A double-blind trial of corticosteroid therapy in status asthmaticus. Pediatrics 54:282–288, 1974PubMedGoogle Scholar
  36. 36.
    Fanta CH, Rossing TH, McFadden ER: Glucocorticoids in acute asthma. Am Rev Respir Dis 125(suppl 3): 94, 1982Google Scholar
  37. 37.
    Loren ML, Chai H, Leung P, Rohr C, Brenner AM: Corticosteroids in the treatment of acute exacerbations of asthma. Ann Allergy 45:67–71, 1980PubMedGoogle Scholar
  38. 38.
    Klaustermeyer WB, Hale FC: The physiologic effect of an intravenous glucocorticoid in bronchial asthma. Ann Allergy 37:80–86, 1976PubMedGoogle Scholar
  39. 39.
    Editorial: Corticosteroids in acute severe asthma. Lancet 2:166–167, 1975Google Scholar
  40. 40.
    Medical Research Council: Cortisone acetate in status asthmaticus. Lancet 2:803–806, 1956Google Scholar
  41. 41.
    Grant IWB: Are corticosteroids necessary in the treatment of severe acute asthma. Br J Dis Chest 76:125–129, 1981Google Scholar
  42. 42.
    Holgate ST, Baldwin CJ: Beta-adrenergic agonists resistance in normal human airways. Lancet 2:375–377, 1977PubMedCrossRefGoogle Scholar
  43. 43.
    Shenfield GM, Hodson ME, Clarke SW, Paterson JW: Interactions of corticosteroids and catecholamines in the treatment of asthma. Thorax 30:430–435, 1975PubMedGoogle Scholar
  44. 44.
    Kattan M, Gurwitz D, Levison H: Corticosteroids in status asthmaticus. J Pediatr 96:596–599, 1980PubMedCrossRefGoogle Scholar
  45. 45.
    Luksza AR: Acute severe asthma treated without steroids. Br J Dis Chest 76:15–19, 1982PubMedGoogle Scholar
  46. 46.
    Luksza AR: A new look at adult asthma. Br J Dis Chest 76:11–14, 1982PubMedGoogle Scholar
  47. 47.
    Dwyer J, Lazarus L, Hickie JB: A study of cortisol metabolism in patients with chronic asthma. Aust Ann Med 16:297–302, 1967PubMedGoogle Scholar
  48. 48.
    Rose JQ, Nickelson JA, Middleton E, Yarchak AM, Park BH, Jusko WJ: Prednisolone disposition in steroid-dependent asthmatics. J Allergy Clin Immunol 66:366–373, 1980PubMedCrossRefGoogle Scholar
  49. 49.
    Collins JV, Harris PWR, Clark TJH, Townsend J: Intravenous corticosteroids in treatment of acute bronchial asthma. Lancet 1:1047–1049, 1980Google Scholar
  50. 50.
    Morris HG: Rational use of corticosteroid therapy, in Berman BA, MacDonnel KF (eds): Differential Diagnosis and Treatment of Pediatric Allergy. Boston, Little Brown, 1981, pp 267–284Google Scholar
  51. 51.
    McFadden ER, Kiser R, deGroot WJ, Holmes B, Kiker R, Viser G: A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma. Am J Med 60:52–59, 1976PubMedCrossRefGoogle Scholar
  52. 52.
    Harfi H, Hanissian AS, Crawford LV: Treatment of status asthmaticus in children with high doses and conventional doses of methylprednisolone. Pediatrics 61:829–831, 1978PubMedGoogle Scholar
  53. 53.
    Krause HA, Santiago SM, Klaustermeyer WB: Intravenously given methylprednisolone in refractory asthma. West J Med 132:106–110, 1980Google Scholar
  54. 54.
    Easton J, Hilman B, Shapiro G, Weinberger M, Anderson J, Buckley J, Eggleston P, Bierman CW: Management of asthma. Pediatrics 68:874–879, 1981Google Scholar
  55. 55.
    Nassif EG, Weinberger M, Thompson R, Huntley W: The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med 304:71–75, 1981PubMedGoogle Scholar
  56. 56.
    The Boston Collaborative Drug Surveillance Program: Acute adverse reactions to prednisone in regulation to dosage. Clin Pharmacol Ther 13:694–698, 1972Google Scholar
  57. 57.
    Vince DJ: Nodular panniculitis after massive prednisone therapy. Can Med Assoc J 79:840–841, 1958PubMedGoogle Scholar
  58. 58.
    Dees SC, McKay HW: Occurrence of pseudotumor cerebri (benign intracranial hypertension) during treatment of children with asthma by adrenal steroids: Report of three cases. Pediatrics 23:1143–1151, 1959PubMedGoogle Scholar
  59. 59.
    Neville BGR, Wilson J: Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J 3:554–556, 1970PubMedCrossRefGoogle Scholar
  60. 60.
    Fraser FC, Walker BE, Fainstat TD: The experimental production of cleft palate with cortisone and other hormones. J Cell Physiol 43(suppl 1):237–259, 1954Google Scholar
  61. 61.
    Fraser FC: Second International Conference on Congenital Malformations. New York, International Medical Congress, 1963Google Scholar
  62. 62.
    Blackburn WR, Kaplan HS, McKay DG: Morphologic changes in the developing rat placenta following prednisolone administration. Am J Obstet Gynecol 92:234–246, 1965PubMedGoogle Scholar
  63. 63.
    Fainstat T: Cortisone induced congenital cleft palate in rabbits. Endocrinology 55:502–508, 1954PubMedGoogle Scholar
  64. 64.
    Liggins GC: Premature parturition after infusion of corticotropin or cortisol into foetal lambs. J Endocrinol 42:323–329, 1968PubMedGoogle Scholar
  65. 65.
    Schatz M, Patterson R, Zeitz S, O’Rourke J, Melam H: Corticosteroid therapy for the pregnant asthmatic patient. J Am Med Assoc 233:804–807, 1975CrossRefGoogle Scholar
  66. 66.
    Plumpton FS, Besser GM, Cole PV: Corticosteroid treatment and surgery. Anesthesia 24:3–18, 1969CrossRefGoogle Scholar
  67. 67.
    Kehlet H: A rational approach to dosage and preparation of parenteral glucocorticoid substitution therapy during surgical procedures. Acta Anesthesiol Scand 19:260–264, 1975CrossRefGoogle Scholar
  68. 68.
    Symreng T, Karlberg BE, Kagedal B, Schildt B: Physiological cortisol substitution of long-term steroid-dependent patients undergoing major surgery. Br J Anaesth, 53:949–954, 1981PubMedCrossRefGoogle Scholar
  69. 69.
    Sahn SA: Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest 73:389–396, 1978PubMedCrossRefGoogle Scholar
  70. 70.
    Albert RK, Martin TR, Lewis SW: Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 92:753–758, 1980PubMedGoogle Scholar
  71. 71.
    Mendella LA, Manfreda J, Warren CPW, Anthonisen NR: Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med 96:17–22, 1982PubMedGoogle Scholar
  72. 72.
    Good RA, Vernier RL, Smith RT: Serious untoward reactions to therapy with cortisone and adrenocorticotropin in pediatric practice. I and II. Pediatrics 19:95–118, 272–284, 1957PubMedGoogle Scholar
  73. 73.
    Melby JC, Silber RH: Clinical pharmacology of water soluble corticosteroid esters. Am Pract 12:156–161, 1961Google Scholar
  74. 74.
    Jubiz W, Meikle AW: Alterations of glucocorticoid actions by other drugs and disease states. Drugs 18:113–121, 1979PubMedCrossRefGoogle Scholar
  75. 75.
    Tulin-Silver J, Schteingart DE, Mathews KP: Effect of theophylline on cortisol secretion. J Allergy Clin Immunol 67:45–50, 1981PubMedCrossRefGoogle Scholar
  76. 76.
    Brooks SM, Sholiton LJ, Werk EE, Altenau P: The effects of ephedrine and theophylline on dexamethasone metabolism in bronchial asthma. J Clin Pharmacol 17:308–318, 1977PubMedGoogle Scholar
  77. 77.
    Hellman L, Bradlow HL, Zumoff B, Gallagher TF: The influence of thyroid hormone on hydrocortisone production and metabolism. J Clin Endocrinol Metab 21:1231–1247, 1961PubMedGoogle Scholar
  78. 78.
    Lange K, Slobody L, Strang RH: Treatment of nephrotic syndrome with interrupted ACTH or cortisone therapy. Proc Soc Exp Biol Med 82:315–317, 1953PubMedGoogle Scholar
  79. 79.
    Siegel SC, Lovin BJ, Ely RS, Kelley VC: Adrenal function in allergy. III. Effect of prolonged intermittent steroid therapy in allergic children. Pediatrics 24:434–447, 1959PubMedGoogle Scholar
  80. 80.
    Malone DNS, Grant IWB, Percy-Robb, IW: Hypothalamo-pituitary-adrenal function in asthmatic patients receiving long-term corticosteroid therapy. Lancet 2:733–735, 1970PubMedCrossRefGoogle Scholar
  81. 81.
    Harter JG, Reddy WJ, Thorn GW: Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 269:591–596, 1963PubMedGoogle Scholar
  82. 82.
    Siegel SC: Corticosteroids and ACTH in the management of the atopic child. Pediatr Clin North Am 16:287–304, 1969PubMedGoogle Scholar
  83. 83.
    Siegel SC, Goldberg M, Richards W, Busser RJ: Effects of alternate-day corticosteroid therapy on linear growth in children with intractable asthma. Isr J Med Sci 6:743, 1970Google Scholar
  84. 84.
    Axelrod L: Glucocorticoid therapy. Medicine 55:39–65, 1975Google Scholar
  85. 85.
    Soyka LF: Alternate-day corticosteroid therapy. Adv Pediatr 19:47–70, 1962Google Scholar
  86. 86.
    Soyka LF: Treatment of nephrotic syndrome in childhood—Use of alternate-day regimen. Am J Dis Child 113:693–701, 1967PubMedGoogle Scholar
  87. 87.
    Morris HG, Neuman I, Ellis EF: Plasma steroid concentrations during alternate-day treatment with prednisone. J Allergy Clin Immunol 54:350–358, 1974CrossRefGoogle Scholar
  88. 88.
    Shapiro GG, Tattoni DS, Kelley VC, Pierson WE, Bierman CW: Growth, pulmonary, and endocrine function in chronic asthma patients on daily and alternate-day adrenocorticosteroid therapy J. Allergy Clin Immunol 57:430–439, 1976CrossRefGoogle Scholar
  89. 89.
    Reimer LG, Morris HG, Ellis EF: Growth of asthmatic children during treatment with alternate-day steroids. J Allergy Clin Immunol 55:224–231, 1975PubMedCrossRefGoogle Scholar
  90. 90.
    O’Neill WM, Etheridge WB, Bloomer A: High-dose corticosteroids: Their use in treating idiopathic rapidly progressive glomerulonephritis. Arch Intern Med 139:514–518, 1979PubMedCrossRefGoogle Scholar
  91. 91.
    Kimberly RP, Lockshin MD, Sherman RL, McDougal JS, Inman RD, Christian CL: High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am J Med 70:817–824, 1981PubMedCrossRefGoogle Scholar
  92. 92.
    Johnson RB, Lazarus GS: Pulse therapy: Therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol 18:76–84, 1982CrossRefGoogle Scholar
  93. 93.
    Miller JJ: Prolonged use of large intravenous steroid pulses in the rheumatic diseases in children. Pediatrics 65:989–994, 1980PubMedGoogle Scholar
  94. 94.
    Liebling MR, Lieb E, McLaughlin K: Pulse methylprednisolone in rheumatoid arthritis: A double-blind cross-over trial. Ann Intern Med 94:21–26, 1981PubMedGoogle Scholar
  95. 95.
    Hess EV, Kammen PL: Pulse therapy in rheumatoid arthritis. Ann Intern Med 94:128–129, 1981PubMedGoogle Scholar
  96. 96.
    Moses RE, McCormick A, Mickey W: Fatal arrhythmia after pulse methylprednisolone therapy. Ann Intern Med 95:781–782, 1981PubMedGoogle Scholar
  97. 97.
    Klinefelter HF, Winkenwerder WL, Bledsoe T: Single daily dose prednisone therapy J Am Med Assoc 241:2721–2723, 1979CrossRefGoogle Scholar
  98. 98.
    Myles AB, Schiller LFG, Glass D, Daily JR: Single daily dose corticosteroid treatment. Ann Rheum Dis 35:73–76, 1976PubMedCrossRefGoogle Scholar
  99. 99.
    Ellis EF, Morris HG, Kiechel F, Pollock JD, Strang LJ: Short-term efficacy and side effects of cloprednol in children with asthma. J Clin Pharmacol 19:675–683, 1979PubMedGoogle Scholar
  100. 100.
    Gavani UD, Hyde JS, Khurana S, Manaligod LM: Long-term cloprednol use in chronic asthma. J Am Med Assoc 242:2679–2682, 1979CrossRefGoogle Scholar
  101. 101.
    Siegel SC, Heimlich EM, Richards W, Kelley VC: Adrenal function in allergy. IV. Effect of dexamethasone aerosols in asthmatic children. Pediatrics 33:245–250, 1964PubMedGoogle Scholar
  102. 102.
    Klein R, Waldman D, Kershnar H, Berger W, Coulson A, Katz R, Rachelefsky GS, Siegel S: Treatment of chronic childhood asthma with beclomethasone dipropionate aerosols. I. A double-blind crossover trial in non-steroid dependent patients. Pediatrics 60:7–13, 1977PubMedGoogle Scholar
  103. 103.
    Kershnar H, Klein R, Waldman D, Berger W, Rachelefsky G, Katz R, Siegel S: Treatment of chronic childhood asthma with beclomethasone dipropionate aerosols. II. Effect on pituitary-adrenal function after substitution for oral corticosteroids. Pediatrics 62:189–197, 1978PubMedGoogle Scholar
  104. 104.
    Andersson E, Smidt CM, Sikjaer B, Ainge G, Poynter D: Bronchial biopsies after beclomethasone dipropionate aerosol. Br J Dis Chest 77:35–43, 1977CrossRefGoogle Scholar
  105. 105.
    DeCotis BA, Settipane GA: The effect of inhaled beclomethasone on serum immunoglobulins. Proc N Engl Soc Allergy 2:153–156, 1981CrossRefGoogle Scholar
  106. 106.
    Soderbert-Warner M, Siegel S, Katz R, Rachelefsky G: Treatment of chronic childhood asthma with beclomethasone dipropionate aerosols (BDA). IV. Long-term effects on growth. J Allergy Clin Immunol 63:164, 1979 (abstract 99).Google Scholar
  107. 107.
    Wyatt R, Waschek J, Weinberger M, Sherman B: Effects of inhaled beclomethasone dipropionate and alternate-day prednisone on pituitary-adrenal function in children with chronic asthma. N Engl J Med 299:1387–1392, 1978PubMedCrossRefGoogle Scholar
  108. 108.
    Vaz R, Senior B, Morris M, Binkiewicz A: Adrenal effects of beclomethasone inhalation therapy in asthmatic children. J Pediatr 100:660–662, 1982PubMedCrossRefGoogle Scholar
  109. 109.
    Mellis CM, Phelan DD: Asthma deaths in children—A continuing problem. Thorax 32:29–34, 1977PubMedGoogle Scholar
  110. 110.
    Harris DM, Martin LE, Harrison C, Jack D: The effect of oral and inhaled beclomethasone dipropionate on adrenal function. Clin Allergy 3:243–248, 1973PubMedCrossRefGoogle Scholar
  111. 111.
    Mygind N, Hansen I: Beclomethasone dipropionate aerosol effect on the adrenals in normal persons. Acta Allergol 28:211–218, 1973PubMedGoogle Scholar
  112. 112.
    Blaiss M, Herrod H, Crawford L, Lieberman P: Beclomethasone dipropionate aerosol: Hematological and immunological effects. Ann Allergy 48:210–214, 1982PubMedGoogle Scholar
  113. 113.
    Nassif E, Weinberger M, Thompson R, Sherman B: Effects of continuous corticosteroid therapy for children with chronic asthma. J Allergy Clin Immunol 65:219–220, 1980 (abstract 183)Google Scholar
  114. 114.
    Godfrey S, Konig, P: Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol. Arch Dis Child 49:591–596, 1974PubMedGoogle Scholar
  115. 115.
    Spitzer SA, Kaufman H, Koplovitz A, Topilsky M, Blum I: Beclomethasone dipropionate and chronic asthma. The effect of long-term aerosol administration on the hypothalamic-piruitary-adrenal axis after substitution for oral therapy with corticosteroids. Chest 70:38–42, 1976PubMedCrossRefGoogle Scholar
  116. 116.
    Spector SL: Response of severe corticosteroid-dependent asthmatic patients to beclomethasone dipropionate aerosol, in Farr RS, Middleton EM Jr, Spector SL (eds): Recent Advances in Asthma Therapy. Miami, Symposia Specialists, 1976, pp 75–80Google Scholar
  117. 117.
    Sherman B, Weinberger M, Chen-Walden H, Wendt H: Further studies of the effects of inhaled glucocorticoids on pituitary-adrenal function in healthy adults. J Allergy Clin Immunol 69:208–212, 1982PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1983

Authors and Affiliations

  • Sheldon C. Siegel
    • 1
  1. 1.From the Pediatric Allergy and Immunology Training ProgramUCLA School of MedicineLos Angeles

Personalised recommendations